Ticker Details
Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of close to 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases.
IPO Date:	December 22, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$10.62B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.99 | 2.13%
Avg Daily Range (30 D):	$1.47 | 1.93%
Avg Daily Range (90 D):	$1.25 | 1.65%

Institutional Daily Volume
Avg Daily Volume:	1.22M
Avg Daily Volume (30 D):	2.08M
Avg Daily Volume (90 D):	1.78M

Trade Size
Avg Trade Size (Sh.):	81
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	12,584
Avg Institutional Trade:	$3.01M
Avg Institutional Trade (30 D):	$5.77M
Avg Institutional Trade (90 D):	$5.82M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$7.34M
Avg Closing Trade (30 D):	$29.92M
Avg Closing Trade (90 D):	$25.47M
Avg Closing Volume:	151.76K

News

Jul 7, 2026 @ 10:42 AM Transthyretin Amyloidosis Treatment Market Size to... Source: Sns Insider

May 18, 2026 @ 6:33 PM Protein Synthesis Research Market to Reach $42.8 B... Source: Bcc Research

May 14, 2026 @ 5:00 PM Oligonucleotides Clinical Trial Drug Development P... Source: Delveinsight

May 14, 2026 @ 3:57 PM Why Is Biogen Stock Falling Thursday? Source: Vandana Singh

May 11, 2026 @ 4:03 PM GSK Targets China's Hepatitis B Market Through New... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.56	$-1.41	$-2.38
Diluted EPS	$-.56	$-1.41	$-2.38
Revenue	$246.09M	$203.33M	$943.71M
Gross Profit	$243.11M	$195.37M	$927.8M
Net Income / Loss	$-92.53M	$-229.39M	$-381.39M
Operating Income / Loss	$-117.42M	$-214.46M	$-381.68M
Cost of Revenue	$2.98M	$7.96M	$15.91M
Net Cash Flow	$-198.74M	$33.96M	$129.48M
PE Ratio